お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949409

神経科デバイス市場:2019年~2025年

Neurology Devices Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
神経科デバイス市場:2019年~2025年
出版日: 2020年05月15日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経科デバイス市場は、予測期間中に大幅な成長が見られると推定されています。神経刺激デバイスの需要の増加は、市場の成長を牽引している要因の1つです。パーキンソン病やアルツハイマー病などの神経障害の有病率の上昇により、神経刺激デバイスの採用が進んでいます。さらに、脊髄損傷の増加により、脊髄刺激(SCS)デバイスの採用がさらに促進されています。National Spinal Cord Injury Statistical Centerによって発表されたデータによると、2019年の時点で、米国では、脊髄損傷の年間発生率は100万人あたり約54症例で、毎年の脊髄損傷の新規症例数は約17,730件となっています。 SCSは通常、手足や体幹の慢性疼痛の治療に使用されます。ただし、脊髄損傷後の制御を強化し、硬直した筋肉を改善することにも役立ちます。したがって、脊髄刺激の需要は、脊髄損傷の治療に大幅に使用される可能性があります。

地理的に、同市場は北米、欧州、アジア太平洋、およびその他の諸国に分類されます。 2018年には、北米での神経疾患の有病率の高まりと相まって、脳神経外科手術の増加により、 北米は市場で大きなシェアを占めると予想されています。アジア太平洋地域では、高齢化と関連する神経疾患により、予測期間中にかなりの成長が見られると推定されています。さらに、神経疾患に関する意識が高まると、脳神経外科手術の数がさらに加速し、それによって、この地域での神経科デバイスの採用が促進されます。

当レポートでは、神経科デバイス市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
  • 規則と規制

第3章 競合情勢

  • 会社シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corp.
    • B. Braun Melsungen AG
    • Stryker Corp.

第4章 市場決定要因

4.1動機

4.2抑制要因

4.3機会

第5章 市場セグメンテーション

  • 製品別世界の神経科デバイス市場
    • 脳脊髄液管理デバイス
    • 神経刺激デバイス
    • インターベンショナル神経科デバイス
    • 脳神経外科デバイス
    • その他
  • エンドユーザー別世界の神経科デバイス市場
    • 病院
    • 神経科クリニック
    • 外来手術センター(ASC)

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Abbott Laboratories
  • Allergan plc
  • Axonics Modulation Technologies, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Dispomedica GmbH
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • LivaNova PLC
  • Magstim Co. Ltd.
  • Medtronic plc
  • Moller Medical GmbH
  • Natus Medical Inc.
  • NeuroPace, Inc.
  • Nevro Corp.
  • Nihon Kohden Corp.
  • Penumbra, Inc.
  • Saluda Medical Pty Ltd.
  • Smith & Nephew plc
  • Stryker Corp.
  • W. L. Gore & Associates, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 2. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL NEUROSTIMULATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL NEUROSURGERY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OTHER NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL NEUROLOGY DEVICES I MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 8. GLOBAL NEUROLOGY DEVICES IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL NEUROLOGY DEVICES IN NEUROLOGY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL NEUROLOGY DEVICES IN AMBULATORY SURGICAL CENTERS (ASCs) MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 15. EUROPEAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 17. EUROPEAN NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD NEUROLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROLOGY DEVICES MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
  • 2. GLOBAL NEUROLOGY DEVICES MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 3. GLOBAL NEUROLOGY DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY NEUROLOGY DEVICESMARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD NEUROLOGY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2021728

Global Neurology Devices Market Size, Share & Trends Analysis Report, By Product (Cerebrospinal Fluid Management Devices, Neurostimulation Devices, Interventional Neurology Devices, Neurosurgery Devices, and Others), By End-User (Hospitals, Neurology Clinics, and Ambulatory Surgical Centers) and Forecast, 2019-2025

The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising spinal cord injuries are further encouraging the adoption of spinal cord stimulation (SCS) devices. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. SCS is normally used for the treatment of chronic pain in the limbs and trunk; however, it can also support enhance control and improve stiff or rigid muscles after a spinal cord injury. Therefore, the demand for spinal cord stimulation may be significantly used to treat spinal cord injuries.

Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2018, North America is anticipated to hold significant share in the market owing to the increasing number of neurosurgeries coupled with the significant prevalence of neurological disorders in the region. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising ageing population and associated neurological disorders in the region. In addition, increasing awareness regarding neurological disorders will further accelerate the number of neurosurgeries, which thereby will drive the adoption of neurology devices in the region.

Some crucial players operating in the market include Medtronic plc, Abbott Laboratories, Boston Scientific Corp., B. Braun Melsungen AG, and Stryker Corp. Mergers and acquisitions and product launches are some crucial strategies adopted by the market players to expand market share and gain a competitive advantage. For instance, in January 2020, Medtronic plc declared the acquisition of Stimgenics, LLC, a provider of novel spinal cord stimulation (SCS) waveform which is known as Differential Target Multiplexed (DTM) SCS. The therapy, which is delivered through the Medtronic Intellis platform, is a new and unique programming option for the treatment of patients suffering from chronic pain. DTM SCS therapy is a new proprietary SCS waveform that will be available on Medtronic Intellis platform.

Research Methodology

The market study of the global neurology devicesmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Neurology DevicesMarket Research and Analysis, By Product
  • Global Neurology DevicesMarket Research and Analysis, By End-User

The Report Covers:

  • Comprehensive research methodology of the global neurology devicesmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global neurology devicesmarket.
  • Insights about market determinants which are stimulating the global neurology devicesmarket.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Medtronic plc
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Abbott Laboratories
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boston Scientific Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. B. Braun Melsungen AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Stryker Corp.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Neurology Devices Market by Product
    • 5.1.1. Cerebrospinal Fluid Management Devices
    • 5.1.2. Neurostimulation Devices
      • 5.1.2.1. Deep Brain Stimulation
      • 5.1.2.2. Spinal Cord Stimulation
      • 5.1.2.3. Sacral Nerve Stimulation
      • 5.1.2.4. Others
    • 5.1.3. Interventional Neurology Devices
      • 5.1.3.1. Aneurysm Coiling and Embolization
      • 5.1.3.2. Neurothrombectomy Devices
      • 5.1.3.3. Neurovascular Catheters
      • 5.1.3.4. Cerebral Balloon Angioplasty &Stents
    • 5.1.4. Neurosurgery Devices
      • 5.1.4.1. Neuroendoscopes
      • 5.1.4.2. Aneurysm Clips
      • 5.1.4.3. Stereotactic Systems
      • 5.1.4.4. Others
    • 5.1.5. Others
  • 5.2. Global Neurology Devices Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Neurology Clinics
    • 5.2.3. Ambulatory Surgical Centers (ASCs)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Allergan plc
  • 7.3. Axonics Modulation Technologies, Inc.
  • 7.4. B. Braun Melsungen AG
  • 7.5. Boston Scientific Corp.
  • 7.6. Dispomedica GmbH
  • 7.7. Integra LifeSciences Holdings Corp.
  • 7.8. Johnson & Johnson Services Inc.
  • 7.9. LivaNova PLC
  • 7.10. Magstim Co. Ltd.
  • 7.11. Medtronic plc
  • 7.12. Moller Medical GmbH
  • 7.13. Natus Medical Inc.
  • 7.14. NeuroPace, Inc.
  • 7.15. Nevro Corp.
  • 7.16. Nihon Kohden Corp.
  • 7.17. Penumbra, Inc.
  • 7.18. Saluda Medical Pty Ltd.
  • 7.19. Smith & Nephew plc
  • 7.20. Stryker Corp.
  • 7.21. W. L. Gore & Associates, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.